8-KRegulation FDExhibits & Filings

CVS HEALTH Corp 8-K Report, Regulation FD Disclosure (Sep 9, 2004)

Filed September 9, 2004For Securities:CVS

Summary

CVS Corporation filed an 8-K on September 9, 2004, to disclose details regarding its acquisition of approximately 1,260 Eckerd drugstores and Eckerd's pharmacy benefits management and mail order businesses (collectively, the 'Southern Business') from J.C. Penney Company, Inc. This significant acquisition, completed on July 31, 2004, expands CVS's footprint, particularly in the southern United States, and strengthens its PBM and mail order capabilities. The filing includes carve-out special purpose financial statements for the Southern Business as of January 31, 2004, and May 1, 2004. However, CVS explicitly notes that pro forma financial statements for the combined entities are not included, and the provided historical information is not necessarily indicative of future performance. Investors should be aware that this information is furnished under Regulation FD and is not automatically incorporated into future SEC filings.

Key Highlights

  • 1CVS Corporation completed the acquisition of approximately 1,260 Eckerd drugstores and Eckerd's pharmacy benefits management/mail order businesses (the 'Southern Business') on July 31, 2004.
  • 2The acquisition significantly expands CVS's retail presence, particularly in the southern U.S. (including Texas and Florida).
  • 3The deal also enhances CVS's capabilities in pharmacy benefits management and mail order pharmacy services.
  • 4The filing includes carve-out special purpose financial statements for the acquired Southern Business as of January 31, 2004, and May 1, 2004.
  • 5CVS stated that pro forma financial statements for the combined entities are not provided in this report.
  • 6Historical financial information for the acquired business is presented on a carve-out basis and is not necessarily indicative of future combined company performance.
  • 7The information is furnished under Regulation FD and will not be incorporated into future SEC filings unless specifically stated.

Frequently Asked Questions

The primary purpose of this 8-K filing was to disclose information related to CVS Corporation's acquisition of the Southern Business from J.C. Penney Company, Inc., which included approximately 1,260 Eckerd drugstores and Eckerd's pharmacy benefits management and mail order operations.

No, the filing explicitly states that pro forma financial statements for the combined companies were not included. It only provides historical financial information on a carve-out basis for the acquired Southern Business.

The filing includes Exhibit 99.1, which contains carve-out special purpose financial statements of the Southern Operations of Eckerd drugstores as of January 31, 2004, and May 1, 2004.

No, the information provided in this 8-K is furnished under Item 7.01 (Regulation FD Disclosure) and is not filed. Therefore, it will not be automatically incorporated by reference into future registration statements unless specifically identified by the Company.